Immunopathogenic mechanisms of rheumatoid arthritis and the use of anti-inflammatory drugs
Intractable & Rare Diseases Research · 31.08.2021 · 10 (3) · 154-164
DOI: 10.5582/irdr.2021.01022 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Intractable & Rare Diseases Research, erschienen am 31.08.2021. Verfasst von Ling Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Sciences College, Shandong Medicinal Biotechnology Centre, Shandong First Medical University, Ji'nan, China. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biomedical Sciences College, Shandong Medicinal Biotechnology Centre, Shandong First Medical University, Ji'nan, China.
- Key Lab for Biotech-Drugs of National Health Commission, Shandong First Medical University, Ji'nan, China.
- Key Lab for Rare & Uncommon Diseases of Shandong Province, Shandong First Medical University, Ji'nan, China.
Zitieren
APA
Zhang, L., Zhang, Y., & Pan, J. (2021). Immunopathogenic mechanisms of rheumatoid arthritis and the use of anti-inflammatory drugs. Intractable & Rare Diseases Research, 10(3), 154-164. https://doi.org/10.5582/irdr.2021.01022
Vancouver
Zhang L, Zhang Y, Pan J. Immunopathogenic mechanisms of rheumatoid arthritis and the use of anti-inflammatory drugs. Intractable & Rare Diseases Research. 2021;10(3):154-164. doi:10.5582/irdr.2021.01022
BibTeX
@article{Zhang2021,
author = {Zhang, Ling and Zhang, Yihang and Pan, Jihong},
title = {Immunopathogenic mechanisms of rheumatoid arthritis and the use of anti-inflammatory drugs},
journal = {Intractable & Rare Diseases Research},
year = {2021},
volume = {10},
number = {3},
pages = {154--164},
doi = {10.5582/irdr.2021.01022}
}
EUVIMED